Reuters :: Health

Teva sues Novartis, Momenta over Copaxone patent

NEW YORK (Reuters) - Teva Pharmaceutical Industries Ltd sued Swiss drugmaker Novartis AG and Momenta Pharmaceuticals Inc on Thursday, accusing them of infringing patents on its multiple sclerosis drug Copaxone. <p><a href="http://feeds.feedburner.com/~a/reuters/healthNews?a=W1XqeX"><img src="http://feeds.feedburner.com/~a/reuters/healthNews?i=W1XqeX" border="0"></img></a></p><div class="feedflare"> <a href="http://feeds.feedburner.com/~f/reuters/healthNews?a=i1V7EK"><img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=i1V7EK" border="0"></img></a> <a href="http://feeds.feedburner.com/~f/reuters/healthNews?a=iwBb8k"><img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=iwBb8k" border="0"></img></a> <a href="http://feeds.feedburner.com/~f/reuters/healthNews?a=yuU6Kk"><img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=yuU6Kk" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/377526214" height="1" width="1"/>